Executive Summary of Joint Task Force Practice Parameters on Diagnosis and Management of Rhinitis.
about
Physiology and pathophysiology of respiratory mucosa of the nose and the paranasal sinuses.Prevention of food and airway allergy: consensus of the Italian Society of Preventive and Social Paediatrics, the Italian Society of Paediatric Allergy and Immunology, and Italian Society of PediatricsResponse to Nonallergenic Irritants in Children With Allergic and Nonallergic Rhinitis.Symptom score for allergic rhinitis.Allergic rhinitis and its impact on asthma. In collaboration with the World Health Organization. Executive summary of the workshop report. 7-10 December 1999, Geneva, Switzerland.Antioxidant status and immune activity of glycyrrhizin in allergic rhinitis mice.Comparison of intranasal corticosteroids and antihistamines in allergic rhinitis: a review of randomized, controlled trials.Pediatric allergic rhinitis: antihistamine selection.Optimal duration of allergic rhinitis clinical trials.Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray: The Ease-of-Use Patient Survey.Clinical characteristics of allergic rhinitis according to allergic rhinitis and its impact on asthma guidelines.Patient adherence to allergic rhinitis treatment: results from patient surveys.Nasal irrigation for chronic sinus symptoms in patients with allergic rhinitis, asthma, and nasal polyposis: a hypothesis generating study.Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies.Allergies in Asia: differences in prevalence and management compared with western populations.Allergen-specific immunoglobulin E and allergic rhinitis severityFluticasone furoate nasal spray: Profile of an enhanced-affinity corticosteroid in treatment of seasonal allergic rhinitis.A review of the use of fluticasone furoate since its launch.The burden of allergic rhinitis and asthma.Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper.Pathophysiology, favoring factors, and associated disorders in otorhinosinusology.Pharmacotherapy of allergic rhinitis: current options and future perspectives.Advances in asthma drug discovery: evaluating the potential of nasal cell sampling and beyond.Bilastine: new insight into antihistamine treatment.A role for the intranasal formulation of azelastine hydrochloride/fluticasone propionate in the treatment of allergic rhinitis.Improvement and prevention of asthma with concomitant treatment of allergic rhinitis and allergen-specific therapy.Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis.The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patients.The health-related quality of life effects of once-daily cetirizine HCl syrup in children with seasonal allergic rhinitis.Rhinitis: do diagnostic criteria affect the prevalence and treatment?Desloratadine therapy improves allergic rhinitis symptoms in latin american children aged 6 to 12 yearsComparing the effects of ketotifen fumarate eye drops and ketotifen oral pills on symptom severity and quality of life in patients with allergic rhinitis: a double-blind randomized clinical trial.Classification of Allergic Rhinitis: What is Most Suitable in Korea?Seasonal Specificity of Seasonal Allergens and Validation of the ARIA Classification in Korea.Mometasone furoate monohydrate nasal spray for the treatment of nasal congestion in allergic rhinitis.Impact of chronic rhinosinusitis on work productivity through one-year follow-up after balloon dilation of the ethmoid infundibulum.Use of intranasal corticosteroids in the management of congestion and sleep disturbance in pediatric patients with allergic rhinitis.Does allergic rhinitis affect communication skills in young adults?Topical Olopatadine Hydrochloride versus Ketotifen Fumarate for Allergic Conjunctivitis.Correlation between Allergic Rhinitis and Laryngopharyngeal Reflux.
P2860
Q24634722-A4BF2E52-09A5-4F3C-BFF1-27CC28F87592Q28074796-C5179BD0-493B-49DE-981C-AFEDEE68B0D4Q30380004-6560B3A6-C49D-4471-B90F-713A3D463F3EQ34594373-F45C3CAB-C415-4920-8F9D-D8B7835D86F2Q34778060-4516A4F3-E5CF-4D5D-ACAA-B7FDB3EA0704Q34874768-2EA586D5-C7C3-477D-B857-88154825CB96Q35627751-B641290E-8EFE-4B76-8AAA-471A8136E094Q36279844-E90A95B1-7A55-4FBB-8A77-1419AE98EE95Q36281063-48D593FB-A5C0-45B4-ACA1-B440749365ACQ36834542-09EB3343-BB0C-425C-8FD6-D48B18C5DBF9Q37165543-E74D86DB-BC9A-4854-BC3B-98815BC41359Q37355776-72EC18F7-EBF6-4A24-BF20-128BB36D8A1FQ37370128-D8A04CC1-68E0-497B-B21D-BAE984BA7AD4Q37599901-3E6955EF-EDF4-4A39-9800-0537A9FB6E7CQ37733524-B6BC69BA-1906-4F3B-9E5E-B41D9BBF8553Q37737430-5C6657AE-3954-47ED-84E2-96476609E79EQ37857678-E36128BD-2836-4958-92CB-BB412A560D1FQ37907340-247C4E99-C285-46FD-A7EF-0328B5DD2184Q37969671-E15A2CFD-5A83-464B-94BE-E58398746191Q37989857-1BAE0AD4-65C6-4B49-A39C-CC4CA4D759DCQ38023963-8B2DD572-89CF-48F9-9613-F8EC98233651Q38161991-F208552F-7B36-47B8-8A36-087AC238A3B8Q38205858-1BAA606C-FBAA-47C6-8047-E044D59EEDE7Q38423124-557A88D7-F7BB-42EC-B70B-288C5FEDB897Q38442701-F54639BA-6809-4AAB-BF8E-76DD2BD8B6E1Q38527351-70ACB0EB-7D20-4F99-B83F-05E9459EEBFFQ38708066-6B581DDC-1FB2-40E3-B39A-5C7951360DDAQ39246987-2238993C-C2A0-4035-8F3D-323511572147Q39400505-52A5390B-7632-49E9-BA42-C102A23E0EE0Q39408538-3E6B1E35-82BF-4915-A4C9-E0C1911EA3C9Q40618056-AAD6AECD-514C-4C6C-BB0D-CEDA76E7FB9CQ41441277-32A44340-4B21-4FA8-8E76-B3BF43695A2FQ42025070-13C27597-313F-4BDD-95E1-B2526BC05811Q42025087-2A40CFAD-69F3-443F-AE3A-CB64595B5E7CQ43061697-55C2C359-03AA-4171-A9F5-532D25B4255CQ45124125-B64BBA47-11DA-4EAF-BF75-FB63113D76F1Q48446467-F43ADCD7-9473-4CF7-8CFB-0392F0942317Q50588426-A786CF5F-93C2-4C4E-BFB0-0A4E654D6829Q55100663-E2E0B968-FB77-4368-B408-DDDC219C14C8Q55366219-5F7A0395-8F62-4A80-8A97-B4C0C497AD73
P2860
Executive Summary of Joint Task Force Practice Parameters on Diagnosis and Management of Rhinitis.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Executive Summary of Joint Tas ...... is and Management of Rhinitis.
@en
Executive Summary of Joint Tas ...... is and Management of Rhinitis.
@nl
type
label
Executive Summary of Joint Tas ...... is and Management of Rhinitis.
@en
Executive Summary of Joint Tas ...... is and Management of Rhinitis.
@nl
prefLabel
Executive Summary of Joint Tas ...... is and Management of Rhinitis.
@en
Executive Summary of Joint Tas ...... is and Management of Rhinitis.
@nl
P1476
Executive Summary of Joint Tas ...... is and Management of Rhinitis.
@en
P2093
Dykewicz MS
P304
P356
10.1016/S1081-1206(10)63152-3
P433
P577
1998-11-01T00:00:00Z